Beam Therapeutics (BEAM) Cash from Operations (2019 - 2026)
Beam Therapeutics (BEAM) reported Cash from Operations of 128513000.0 for Q1 2026, down 23.71% year-over-year from 168449239.69 in Q1 2025, and down 54.3% quarter-over-quarter from 83289000.0 in Q4 2025.
Beam Therapeutics (BEAM) Cash from Operations (2019 - 2026) Analysis & Trends
Beam Therapeutics (BEAM) has 8 years of Cash from Operations data on file, last reported at 128513000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 128513000.0, down 23.71% year-over-year; the trailing twelve-month figure through Mar 2026 was 369731000.0 (down 5.22% YoY), and the FY2025 annual result was 345102000.0, up 0.62% from the prior year.
- Cash from Operations slipped to 128513000.0 in Q1 2026 per BEAM's latest filing, from 83289000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 218490000.0 in Q1 2022 and troughed at 128513000.0 in Q1 2026.
- A 5-year average of 55737000.0 and a median of 83009000.0 in 2024 frame the typical range for Cash from Operations.
- On a YoY basis, Cash from Operations climbed as much as 666.36% in 2022 and fell as far as 3880.93% in 2022.
- A 5-year view of Cash from Operations shows it stood at 69191000.0 in 2022, then soared by 295.22% to 135073000.0 in 2023, then sank by 156.54% to 76365000.0 in 2024, then slipped by 9.07% to 83289000.0 in 2025, then slumped by 54.3% to 128513000.0 in 2026.
- Business Quant data shows BEAM's Cash from Operations at 128513000.0 in Q1 2026, 83289000.0 in Q4 2025, and 81479000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Beam Therapeutics | 3.53 Bn | 3.53 Bn | - | -128.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128.51 Mn |
| Mar 31, 2026 | -128.51 Mn |
| Dec 31, 2025 | -83.29 Mn |
| Dec 31, 2025 | -83.29 Mn |
| Sep 30, 2025 | -81.48 Mn |
| Sep 30, 2025 | -81.48 Mn |
| Jun 30, 2025 | -76.45 Mn |
| Jun 30, 2025 | -76.45 Mn |
| Mar 31, 2025 | -103.88 Mn |
| Mar 31, 2025 | -103.88 Mn |
| Dec 31, 2024 | -76.37 Mn |
| Dec 31, 2024 | -76.37 Mn |
| Sep 30, 2024 | -88.13 Mn |
| Sep 30, 2024 | -88.13 Mn |
| Jun 30, 2024 | -83.01 Mn |
| Jun 30, 2024 | -83.01 Mn |
| Mar 31, 2024 | -99.75 Mn |
| Mar 31, 2024 | -99.75 Mn |
| Dec 31, 2023 | 135.07 Mn |
| Dec 31, 2023 | 135.07 Mn |